139 related articles for article (PubMed ID: 34530383)
21. Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors.
Svobodova B; Mezeiova E; Hepnarova V; Hrabinova M; Muckova L; Kobrlova T; Jun D; Soukup O; Jimeno ML; Marco-Contelles J; Korabecny J
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31430943
[TBL] [Abstract][Full Text] [Related]
22. 1H-1,2,3-triazole grafted tacrine-chalcone conjugates as potential cholinesterase inhibitors with the evaluation of their behavioral tests and oxidative stress in mice brain cells.
Rani A; Singh A; Kaur J; Singh G; Bhatti R; Gumede N; Kisten P; Singh P; Sumanjit ; Kumar V
Bioorg Chem; 2021 Sep; 114():105053. PubMed ID: 34120027
[TBL] [Abstract][Full Text] [Related]
23. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
[TBL] [Abstract][Full Text] [Related]
24. Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE.
Wang H; Carlier PR; Ho WL; Wu DC; Lee NT; Li CP; Pang YP; Han YF
Neuroreport; 1999 Mar; 10(4):789-93. PubMed ID: 10208549
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
[TBL] [Abstract][Full Text] [Related]
26. Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions.
Carlier PR; Chow ES; Han Y; Liu J; El Yazal J; Pang YP
J Med Chem; 1999 Oct; 42(20):4225-31. PubMed ID: 10514292
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of huperzine B on cholinesterase activity in mice.
Liu J; Zhang HY; Wang LM; Tang XC
Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):141-5. PubMed ID: 10437161
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of novel tacrine-dipicolylamine dimers that are multiple-target-directed ligands with potential to treat Alzheimer's disease.
Zhang P; Wang Z; Mou C; Zou J; Xie Y; Liu Z; Benjamin Naman C; Mao Y; Wei J; Huang X; Dong J; Yang M; Wang N; Jin H; Liu F; Lin D; Liu H; Zhou F; He S; Zhang B; Cui W
Bioorg Chem; 2021 Nov; 116():105387. PubMed ID: 34628225
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and evaluation of novel 5,6,7-trimethoxyflavone-6-chlorotacrine hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Liao S; Deng H; Huang S; Yang J; Wang S; Yin B; Zheng T; Zhang D; Liu J; Gao G; Ma J; Deng Z
Bioorg Med Chem Lett; 2015 Apr; 25(7):1541-5. PubMed ID: 25724825
[TBL] [Abstract][Full Text] [Related]
30. Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.
Chalupova K; Korabecny J; Bartolini M; Monti B; Lamba D; Caliandro R; Pesaresi A; Brazzolotto X; Gastellier AJ; Nachon F; Pejchal J; Jarosova M; Hepnarova V; Jun D; Hrabinova M; Dolezal R; Zdarova Karasova J; Mzik M; Kristofikova Z; Misik J; Muckova L; Jost P; Soukup O; Benkova M; Setnicka V; Habartova L; Chvojkova M; Kleteckova L; Vales K; Mezeiova E; Uliassi E; Valis M; Nepovimova E; Bolognesi ML; Kuca K
Eur J Med Chem; 2019 Apr; 168():491-514. PubMed ID: 30851693
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, cholinesterase inhibition and molecular modelling study of novel tacrine hybrids with carbohydrate derivatives.
Lopes JPB; Silva L; da Costa Franarin G; Antonio Ceschi M; Seibert Lüdtke D; Ferreira Dantas R; de Salles CMC; Paes Silva-Jr F; Roberto Senger M; Alvim Guedes I; Emmanuel Dardenne L
Bioorg Med Chem; 2018 Nov; 26(20):5566-5577. PubMed ID: 30340901
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and Cholinesterase Inhibitory Activity of N-Phosphorylated/ N-Tiophosphorylated Tacrine.
Przybyłowska M; Inkielewicz-Stepniak I; Kowalski S; Dzierzbicka K; Demkowicz S; Daśko M
Med Chem; 2020; 16(7):947-957. PubMed ID: 31309898
[TBL] [Abstract][Full Text] [Related]
33. Tacrine Induces Endoplasmic Reticulum-Stressed Apoptosis via Disrupting the Proper Assembly of Oligomeric Acetylcholinesterase in Cultured Neuronal Cells.
Liu EYL; Mak S; Kong X; Xia Y; Kwan KKL; Xu ML; Tsim KWK
Mol Pharmacol; 2021 Nov; 100(5):456-469. PubMed ID: 34531295
[TBL] [Abstract][Full Text] [Related]
34. Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors.
Roldán-Peña JM; Romero-Real V; Hicke J; Maya I; Franconetti A; Lagunes I; Padrón JM; Petralla S; Poeta E; Naldi M; Bartolini M; Monti B; Bolognesi ML; López Ó; Fernández-Bolaños JG
Eur J Med Chem; 2019 Nov; 181():111550. PubMed ID: 31376562
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors.
Mo J; Yang H; Chen T; Li Q; Lin H; Feng F; Liu W; Qu W; Guo Q; Chi H; Chen Y; Sun H
Bioorg Chem; 2019 Dec; 93():103310. PubMed ID: 31586704
[TBL] [Abstract][Full Text] [Related]
37. Potent Acetylcholinesterase Selective and Reversible Homodimeric Agent Based on Tacrine for Theranostics.
Meena VK; Chaturvedi S; Sharma RK; Mishra AK; Hazari PP
Mol Pharm; 2019 Jun; 16(6):2296-2308. PubMed ID: 31059278
[TBL] [Abstract][Full Text] [Related]
38. Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids as Multifunctional Drug Candidates against Alzheimer's Disease.
Fu Y; Mu Y; Lei H; Wang P; Li X; Leng Q; Han L; Qu X; Wang Z; Huang X
Molecules; 2016 Oct; 21(10):. PubMed ID: 27727187
[TBL] [Abstract][Full Text] [Related]
39. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Chen Y; Zhu J; Mo J; Yang H; Jiang X; Lin H; Gu K; Pei Y; Wu L; Tan R; Hou J; Chen J; Lv Y; Bian Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):290-302. PubMed ID: 29278947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
